InvestorsHub Logo

hoffmann6383

10/02/22 8:01 AM

#518382 RE: jammy32 #518375

I disagree with this false price ceiling. If I were short I'd be setting these sort of fake price ceilings.

vator

10/02/22 8:48 AM

#518393 RE: jammy32 #518375

From my posts this morning you know I am not all sunshine and rainbows but I can easily come up with an over $100 per share price. As a platform for all cancer operable and inoperable you could get a million patients a year. You can do the math at $200K a pop.

But that dream keeps fading as I watch management stumble.

biosectinvestor

10/02/22 3:34 PM

#518497 RE: jammy32 #518375

I have an example just the other day of how reasonable it would be if the company got only 15,000 patients for GBM alone in the markets it is in only currently, and how that could easily generate a substantial price per share with 1.5 billions shares outstanding. If it extends the indications beyond GBM to new and recurrent cancers in various indications, and assuming the Flaskworks scaling works in terms of manufacturing, which I have no reason to not expect, in a few years it certainly could reach a very substantial market cap, engage in share buybacks and reach a substantial per share value.

Plus you can have irrational enthusiasm as we see with Tesla.